United States Gabapentin Market Report 2017

January 2018 | 102 pages | ID: UE353B30CBFEN
QYResearch

Abstracts

In this report, the United States Gabapentin market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Gabapentin in these regions, from 2012 to 2022 (forecast).

United States Gabapentin market competition by top manufacturers/players, with Gabapentin sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Pfizer
• GSK
• Sailike
• Jiangsu Enhua
• Jiangsu Hengrui
• Novartis
• Actavis
• Glenmark

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Tablet
• Capsule

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Nerve Pain
• Restless Legs Syndrome
• Seizures

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Gabapentin Market Report 2017

1 GABAPENTIN OVERVIEW

1.1 Product Overview and Scope of Gabapentin
1.2 Classification of Gabapentin by Product Category
  1.2.1 United States Gabapentin Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Gabapentin Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Tablet
  1.2.4 Capsule
1.3 United States Gabapentin Market by Application/End Users
  1.3.1 United States Gabapentin Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Nerve Pain
  1.3.3 Restless Legs Syndrome
  1.3.4 Seizures
1.4 United States Gabapentin Market by Region
  1.4.1 United States Gabapentin Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Gabapentin Status and Prospect (2012-2022)
  1.4.3 Southwest Gabapentin Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Gabapentin Status and Prospect (2012-2022)
  1.4.5 New England Gabapentin Status and Prospect (2012-2022)
  1.4.6 The South Gabapentin Status and Prospect (2012-2022)
  1.4.7 The Midwest Gabapentin Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Gabapentin (2012-2022)
  1.5.1 United States Gabapentin Sales and Growth Rate (2012-2022)
  1.5.2 United States Gabapentin Revenue and Growth Rate (2012-2022)

2 UNITED STATES GABAPENTIN MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Gabapentin Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Gabapentin Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Gabapentin Average Price by Players/Suppliers (2012-2017)
2.4 United States Gabapentin Market Competitive Situation and Trends
  2.4.1 United States Gabapentin Market Concentration Rate
  2.4.2 United States Gabapentin Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Gabapentin Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES GABAPENTIN SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Gabapentin Sales and Market Share by Region (2012-2017)
3.2 United States Gabapentin Revenue and Market Share by Region (2012-2017)
3.3 United States Gabapentin Price by Region (2012-2017)

4 UNITED STATES GABAPENTIN SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Gabapentin Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Gabapentin Revenue and Market Share by Type (2012-2017)
4.3 United States Gabapentin Price by Type (2012-2017)
4.4 United States Gabapentin Sales Growth Rate by Type (2012-2017)

5 UNITED STATES GABAPENTIN SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Gabapentin Sales and Market Share by Application (2012-2017)
5.2 United States Gabapentin Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES GABAPENTIN PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Pfizer
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Gabapentin Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Pfizer Gabapentin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 GSK
  6.2.2 Gabapentin Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 GSK Gabapentin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Sailike
  6.3.2 Gabapentin Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Sailike Gabapentin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Jiangsu Enhua
  6.4.2 Gabapentin Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Jiangsu Enhua Gabapentin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Jiangsu Hengrui
  6.5.2 Gabapentin Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Jiangsu Hengrui Gabapentin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Novartis
  6.6.2 Gabapentin Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Novartis Gabapentin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Actavis
  6.7.2 Gabapentin Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Actavis Gabapentin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Glenmark
  6.8.2 Gabapentin Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Glenmark Gabapentin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview

7 GABAPENTIN MANUFACTURING COST ANALYSIS

7.1 Gabapentin Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Gabapentin

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Gabapentin Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Gabapentin Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES GABAPENTIN MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Gabapentin Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Gabapentin Sales Volume Forecast by Type (2017-2022)
11.3 United States Gabapentin Sales Volume Forecast by Application (2017-2022)
11.4 United States Gabapentin Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Gabapentin
Figure United States Gabapentin Market Size (K Units) by Type (2012-2022)
Figure United States Gabapentin Sales Volume Market Share by Type (Product Category) in 2016
Figure Tablet Product Picture
Figure Capsule Product Picture
Figure United States Gabapentin Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Gabapentin by Application in 2016
Figure Nerve Pain Examples
Table Key Downstream Customer in Nerve Pain
Figure Restless Legs Syndrome Examples
Table Key Downstream Customer in Restless Legs Syndrome
Figure Seizures Examples
Table Key Downstream Customer in Seizures
Figure United States Gabapentin Market Size (Million USD) by Region (2012-2022)
Figure The West Gabapentin Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Gabapentin Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Gabapentin Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Gabapentin Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Gabapentin Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Gabapentin Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Gabapentin Sales (K Units) and Growth Rate (2012-2022)
Figure United States Gabapentin Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Gabapentin Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Gabapentin Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Gabapentin Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Gabapentin Sales Share by Players/Suppliers
Figure 2017 United States Gabapentin Sales Share by Players/Suppliers
Figure United States Gabapentin Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Gabapentin Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Gabapentin Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Gabapentin Revenue Share by Players/Suppliers
Figure 2017 United States Gabapentin Revenue Share by Players/Suppliers
Table United States Market Gabapentin Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Gabapentin Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Gabapentin Market Share of Top 3 Players/Suppliers
Figure United States Gabapentin Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Gabapentin Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Gabapentin Product Category
Table United States Gabapentin Sales (K Units) by Region (2012-2017)
Table United States Gabapentin Sales Share by Region (2012-2017)
Figure United States Gabapentin Sales Share by Region (2012-2017)
Figure United States Gabapentin Sales Market Share by Region in 2016
Table United States Gabapentin Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Gabapentin Revenue Share by Region (2012-2017)
Figure United States Gabapentin Revenue Market Share by Region (2012-2017)
Figure United States Gabapentin Revenue Market Share by Region in 2016
Table United States Gabapentin Price (USD/Unit) by Region (2012-2017)
Table United States Gabapentin Sales (K Units) by Type (2012-2017)
Table United States Gabapentin Sales Share by Type (2012-2017)
Figure United States Gabapentin Sales Share by Type (2012-2017)
Figure United States Gabapentin Sales Market Share by Type in 2016
Table United States Gabapentin Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Gabapentin Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Gabapentin by Type (2012-2017)
Figure Revenue Market Share of Gabapentin by Type in 2016
Table United States Gabapentin Price (USD/Unit) by Types (2012-2017)
Figure United States Gabapentin Sales Growth Rate by Type (2012-2017)
Table United States Gabapentin Sales (K Units) by Application (2012-2017)
Table United States Gabapentin Sales Market Share by Application (2012-2017)
Figure United States Gabapentin Sales Market Share by Application (2012-2017)
Figure United States Gabapentin Sales Market Share by Application in 2016
Table United States Gabapentin Sales Growth Rate by Application (2012-2017)
Figure United States Gabapentin Sales Growth Rate by Application (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Gabapentin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Gabapentin Sales Growth Rate (2012-2017)
Figure Pfizer Gabapentin Sales Market Share in United States (2012-2017)
Figure Pfizer Gabapentin Revenue Market Share in United States (2012-2017)
Table GSK Basic Information List
Table GSK Gabapentin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GSK Gabapentin Sales Growth Rate (2012-2017)
Figure GSK Gabapentin Sales Market Share in United States (2012-2017)
Figure GSK Gabapentin Revenue Market Share in United States (2012-2017)
Table Sailike Basic Information List
Table Sailike Gabapentin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sailike Gabapentin Sales Growth Rate (2012-2017)
Figure Sailike Gabapentin Sales Market Share in United States (2012-2017)
Figure Sailike Gabapentin Revenue Market Share in United States (2012-2017)
Table Jiangsu Enhua Basic Information List
Table Jiangsu Enhua Gabapentin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Jiangsu Enhua Gabapentin Sales Growth Rate (2012-2017)
Figure Jiangsu Enhua Gabapentin Sales Market Share in United States (2012-2017)
Figure Jiangsu Enhua Gabapentin Revenue Market Share in United States (2012-2017)
Table Jiangsu Hengrui Basic Information List
Table Jiangsu Hengrui Gabapentin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Jiangsu Hengrui Gabapentin Sales Growth Rate (2012-2017)
Figure Jiangsu Hengrui Gabapentin Sales Market Share in United States (2012-2017)
Figure Jiangsu Hengrui Gabapentin Revenue Market Share in United States (2012-2017)
Table Novartis Basic Information List
Table Novartis Gabapentin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novartis Gabapentin Sales Growth Rate (2012-2017)
Figure Novartis Gabapentin Sales Market Share in United States (2012-2017)
Figure Novartis Gabapentin Revenue Market Share in United States (2012-2017)
Table Actavis Basic Information List
Table Actavis Gabapentin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Actavis Gabapentin Sales Growth Rate (2012-2017)
Figure Actavis Gabapentin Sales Market Share in United States (2012-2017)
Figure Actavis Gabapentin Revenue Market Share in United States (2012-2017)
Table Glenmark Basic Information List
Table Glenmark Gabapentin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Glenmark Gabapentin Sales Growth Rate (2012-2017)
Figure Glenmark Gabapentin Sales Market Share in United States (2012-2017)
Figure Glenmark Gabapentin Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Gabapentin
Figure Manufacturing Process Analysis of Gabapentin
Figure Gabapentin Industrial Chain Analysis
Table Raw Materials Sources of Gabapentin Major Players/Suppliers in 2016
Table Major Buyers of Gabapentin
Table Distributors/Traders List
Figure United States Gabapentin Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Gabapentin Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Gabapentin Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Gabapentin Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Gabapentin Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Gabapentin Sales Volume (K Units) Forecast by Type in 2022
Table United States Gabapentin Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Gabapentin Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Gabapentin Sales Volume (K Units) Forecast by Application in 2022
Table United States Gabapentin Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Gabapentin Sales Volume Share Forecast by Region (2017-2022)
Figure United States Gabapentin Sales Volume Share Forecast by Region (2017-2022)
Figure United States Gabapentin Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources